CL2008000103A1 - Proteina de fusion que comprende los antigenos de cancer testicular o fragmentos de los mismos ny-eso-1 enlazado con lage-1, en donde al menos uno esta truncado, o incluye uno o mas epitopos de ny-eso-1 o lage-1; acido nucleico que la codifica; compo - Google Patents

Proteina de fusion que comprende los antigenos de cancer testicular o fragmentos de los mismos ny-eso-1 enlazado con lage-1, en donde al menos uno esta truncado, o incluye uno o mas epitopos de ny-eso-1 o lage-1; acido nucleico que la codifica; compo

Info

Publication number
CL2008000103A1
CL2008000103A1 CL200800103A CL2008000103A CL2008000103A1 CL 2008000103 A1 CL2008000103 A1 CL 2008000103A1 CL 200800103 A CL200800103 A CL 200800103A CL 2008000103 A CL2008000103 A CL 2008000103A CL 2008000103 A1 CL2008000103 A1 CL 2008000103A1
Authority
CL
Chile
Prior art keywords
lage
eso
codifies
compo
epitopes
Prior art date
Application number
CL200800103A
Other languages
English (en)
Inventor
Normand Blais
Martine Boyer
Vincent Brichard
Jamila Louahed
Remi M Palmantier
Clement Rioux
Original Assignee
Glaxosmithkline Biolog Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0700759A external-priority patent/GB0700759D0/en
Priority claimed from GB0701262A external-priority patent/GB0701262D0/en
Application filed by Glaxosmithkline Biolog Sa filed Critical Glaxosmithkline Biolog Sa
Publication of CL2008000103A1 publication Critical patent/CL2008000103A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A61K39/001184—Cancer testis antigens, e.g. SSX, BAGE, GAGE or SAGE
    • A61K39/001188—NY-ESO
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55561—CpG containing adjuvants; Oligonucleotide containing adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
CL200800103A 2007-01-15 2008-01-14 Proteina de fusion que comprende los antigenos de cancer testicular o fragmentos de los mismos ny-eso-1 enlazado con lage-1, en donde al menos uno esta truncado, o incluye uno o mas epitopos de ny-eso-1 o lage-1; acido nucleico que la codifica; compo CL2008000103A1 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0700759A GB0700759D0 (en) 2007-01-15 2007-01-15 Novel fusion protein
GB0701262A GB0701262D0 (en) 2007-01-23 2007-01-23 Vaccine
US91484807P 2007-04-30 2007-04-30

Publications (1)

Publication Number Publication Date
CL2008000103A1 true CL2008000103A1 (es) 2008-07-18

Family

ID=39636996

Family Applications (1)

Application Number Title Priority Date Filing Date
CL200800103A CL2008000103A1 (es) 2007-01-15 2008-01-14 Proteina de fusion que comprende los antigenos de cancer testicular o fragmentos de los mismos ny-eso-1 enlazado con lage-1, en donde al menos uno esta truncado, o incluye uno o mas epitopos de ny-eso-1 o lage-1; acido nucleico que la codifica; compo

Country Status (4)

Country Link
AR (1) AR064863A1 (es)
AU (1) AU2008206463B2 (es)
CL (1) CL2008000103A1 (es)
PT (1) PT2118128E (es)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ522066A (en) * 2000-03-30 2004-08-27 Dendreon Corp Compositions and methods for dendritic cell-based immunotherapy
AU2004314347B2 (en) * 2003-12-24 2011-05-19 Aduro Biotech, Inc. Recombinant nucleic acid molecules encoding fusion proteins comprising antigens and bacterial secretory signal polypeptides, expression cassettes, and bacteria, and methods of use thereof

Also Published As

Publication number Publication date
AU2008206463A1 (en) 2008-07-24
AU2008206463B2 (en) 2013-04-04
PT2118128E (pt) 2013-01-29
AR064863A1 (es) 2009-04-29

Similar Documents

Publication Publication Date Title
CL2007002070A1 (es) Anticuerpo quimerico o humanizado, o fragmentos de ellos, que se adhieren especificamente a por lo menos un epitopo en la proteina beta-amiloide; molecula de acido nucleico que lo codifica; composicion que lo comprende; su uso para tratar enfermedade
CL2007003291A1 (es) Anticuerpo monoclonal humano aislado que enlaza la proteina btla o fragmentos del mismo; acido nucleico que lo codifica; metodo de produccion; composicion e inmunoconjugado que los comprende; y metodo para inhibir el crecimiento de celulas de tumor e
HK1245824A1 (zh) 截短的actriib-fc融合蛋白
CL2014000400A1 (es) Proteina de union al antigeno especifica para el heterodimero alfa4beta7; y composicion que la comprende (div.sol.n°2306-11).
CL2007000478A1 (es) Anticuerpo humano o humanizado o fragmento funcional del mismo especifico para linfopoyetina estromal timica, tslp; polinucleotido que lo codifica; celula huesped que lo comprende; composicion farmaceutica que comprende al anticuerpo; y metodo para t
GT201500054A (es) Moléculas de enlace a il-18
BRPI0710645A2 (pt) Anticorpos que se ligam à proteína humana tirosina fosfatase beta (hptpbeta) e usos dos mesmos
ECSP11011445A (es) Composiciones y métodos para anticuerpos que se dirigen a la proteína de complemento c3b
PA8794201A1 (es) Anticuerpos anti-cxcr5 humanizados, derivados de los mismos y su uso
CL2013000459A1 (es) Anticuerpo aislado o fragmento que se enlaza a un estado inactivo de un receptor her; composicion farmaceutica que lo comprende; uso del anticuerpo para tratar cancer.
DK3332808T3 (da) Humaniserede L243-antistoffer
CL2012001141A1 (es) Anticuerpo aislado o fragmento de este que se une específicamente a interleuquina-17a (il-17a) humana.
BRPI0918947A2 (pt) proteína de fusão de anticorpo
CR10298A (es) Metodos y composiciones para antagonismo de rage
CL2008003784A1 (es) Anticuerpo humanizado anti proteina e2 del virus de la hepatitis c o un fragmento de union; acido nucleico que lo codifica; vector y celula huesped que comprenden dicho acido nucleico; metodo para producir el anticuerpo; composicion farmaceutica que comprende el anticuerpo
BRPI0716761A2 (pt) painel de revestimento para uma fuselagem de aeronave
FR2952908B1 (fr) Ensemble pour turboreacteur d'aeronef
DK2118128T3 (da) Fusionsproteiner omfattende tumorrejektionantigenerne NY-ESO-1 og LAGE-1
BRPI0814127A2 (pt) Polipeptídeos imunegênicos e anticorpos monoclonais
BRPI0914782A2 (pt) peptídeos de epítopos de cdca1 e vacinas contendo os mesmos
EP3650547A4 (en) MONOCLONAL ANTI-HUMAN IGG4 ANTIBODY AND HUMAN IGG4 ASSAY REAGENT USING THIS ANTIBODY
DK1910050T3 (da) Fremgangsmåde til forbedring af hakket aramidfibers filamentsammenhængsevne
BRPI0906234A2 (pt) Fuselagem de aeronave resistente à requema
BRPI0715544A2 (pt) Anticorpos que modificam doença cancerosas.
AR077952A1 (es) Resistencia contra oomycota en plantas mediada por fusion de anticuerpos